RT Journal Article
SR Electronic
T1 Delayed generation of functional virus-specific circulating T follicular helper cells correlates with severe COVID-19
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2022.07.12.22277549
DO 10.1101/2022.07.12.22277549
A1 Yu, Meng
A1 Charles, Afandi
A1 Cagigi, Alberto
A1 Christ, Wanda
A1 Österberg, Björn
A1 Falck-Jones, Sara
A1 Azizmohammadi, Lida
A1 Åhlberg, Eric
A1 Falck-Jones, Ryan
A1 Svensson, Julia
A1 Nie, Mu
A1 Warnqvist, Anna
A1 Hellgren, Fredrika
A1 Lenart, Klara
A1 Cerveira, Rodrigo Arcoverde
A1 Ols, Sebastian
A1 Lindgren, Gustaf
A1 Lin, Ang
A1 Maecker, Holden
A1 Bell, Max
A1 Johansson, Niclas
A1 Albert, Jan
A1 Sundling, Christopher
A1 Czarnewski, Paulo
A1 Klingström, Jonas
A1 Färnert, Anna
A1 Loré, Karin
A1 Smed-Sörensen, Anna
YR 2022
UL http://medrxiv.org/content/early/2022/07/12/2022.07.12.22277549.abstract
AB Effective humoral immune responses require well-orchestrated cellular interactions between B and T follicular helper (Tfh) cells. Whether this interaction is impaired and associated with COVID-19 disease severity is unknown. Here, longitudinal acute and convalescent blood samples from 49 COVID-19 patients across mild to severe disease were analysed. We found that during acute infection activated and SARS-CoV-2-specific circulating Tfh (cTfh) cell frequencies expanded with increasing disease severity. The frequency of activated and SARS-CoV-2-specific cTfh cells correlated with plasmablast frequencies and SARS-CoV-2 antibody titers, avidity and neutralization. Furthermore, cTfh cells but not other memory CD4 T cells, isolated from severe patients induced more pronounced differentiation of autologous plasmablast and antibody production in vitro compared to cTfh cells isolated from mild patients. However, the development of virus-specific cTfh cells was delayed in patients that displayed or later developed severe disease compared to those that maintained a mild or moderate disease. This correlated with a delayed induction of high-avidity and neutralizing virus-specific antibodies. Our study therefore suggests that impaired generation of functional virus-specific cTfh cells delays the production of high-quality antibodies to combat the infection at an early stage and thereby enabling progression to more severe COVID-19 disease.Competing Interest StatementAnna Smed-Sorensen is a consultant for Astra Zeneca on studies unrelated to this research. All other authors declare no conflict of interests.Funding StatementThis work was supported by grants from the Swedish Research Council, the Swedish Heart-Lung Foundation, the Bill & Melinda Gates Foundation, the Knut and Alice Wallenberg Foundation through SciLifeLab and Karolinska Institutet.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study was approved by the Swedish Ethical Review Authority (Ethical permit:2015/1949-31/4), and performed according to the Declaration of Helsinki.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present work are contained in the manuscript